Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Jodie M Fleming"'
Autor:
Denise K Reaves, Katerina D Fagan-Solis, Karen Dunphy, Shannon D Oliver, David W Scott, Jodie M Fleming
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e91747 (2014)
The claudin-low molecular subtype of breast cancer is of particular interest for clinically the majority of these tumors are poor prognosis, triple negative, invasive ductal carcinomas. Claudin-low tumors are characterized by cancer stem cell-like fe
Externí odkaz:
https://doaj.org/article/35a135e0970142ddb4b58b410da754fa
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e34058 (2012)
Previously we demonstrated that EpH4 mouse mammary epithelial cells induced the homeobox transcription factor Msx2 either when transfected with the progesterone receptor (PR) or when treated with Bmp2/4. Msx2 upregulation was unaffected by Wnt inhibi
Externí odkaz:
https://doaj.org/article/de8023aa4ea74123a5ca8d38dd5dae79
Autor:
Ria D. Corder, Robert B. Vachieri, Megan E. Martin, Darlene K. Taylor, Jodie M. Fleming, Saad A. Khan
Publikováno v:
Biomaterials Science. 11:2186-2199
The effects of injectable, localized liberase treatments on the linear and nonlinear rheology of allograft 4T1 mouse mammary tumors are examined, demonstrating how insights about the tumor microenvironment can be gleaned from the rheological data.
Autor:
Linnea T. Olsson, Andrea Walens, Alina M. Hamilton, Halei C. Benefield, Jodie M. Fleming, Lisa A. Carey, Stephen D. Hursting, Kevin P. Williams, Melissa A. Troester
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: Obese women have higher risk of aggressive breast tumors and distant metastasis. However, obesity has rarely been assessed in association with metastasis in diverse populations. Methods: In the Carolina Breast Cancer Study Phase 3 (2008
Autor:
Jodie M. Fleming, Charles M. Perou, Melissa A. Troester, David McDonald, Jyla Hicks, Lynnelle Thorpe, Michael Bereman, Dereje D. Jima, Katerina D. Fagan-Solis, Katherine A. Hoadley, Denise K. Reaves
Supplementary Table 1. Mutations in LSR from Human Cancer Samples. Supplementary Table 2. Potential post-translational modification sites of LSR transcript variants.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ba4ab2e5d01dfc8e5347f106d3e0252
https://doi.org/10.1158/1541-7786.22511797.v1
https://doi.org/10.1158/1541-7786.22511797.v1
Autor:
Jodie M. Fleming, Charles M. Perou, Melissa A. Troester, David McDonald, Jyla Hicks, Lynnelle Thorpe, Michael Bereman, Dereje D. Jima, Katerina D. Fagan-Solis, Katherine A. Hoadley, Denise K. Reaves
Lipolysis-stimulated lipoprotein receptor (LSR) has been found in the plasma membrane and is believed to function in lipoprotein endocytosis and tight junctions. Given the impact of cellular metabolism and junction signaling pathways on tumor phenoty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5d7e8d3ce895b29e51f9dc2fa25af6f
https://doi.org/10.1158/1541-7786.c.6540046.v1
https://doi.org/10.1158/1541-7786.c.6540046.v1
Autor:
Jodie M. Fleming, Charles M. Perou, Melissa A. Troester, David McDonald, Jyla Hicks, Lynnelle Thorpe, Michael Bereman, Dereje D. Jima, Katerina D. Fagan-Solis, Katherine A. Hoadley, Denise K. Reaves
S1. QPCR analysis of luminal progenitor and cancer stem cell genes. Primers were designed against the indicated genes. S2. Representative Z-stack projections of MCF7 breast cancer and MCF10AI breast epithelial cells generated from deconvolved slices
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cafe6fdba6802f38d63e2374029ad22b
https://doi.org/10.1158/1541-7786.22511803.v1
https://doi.org/10.1158/1541-7786.22511803.v1
Autor:
Jodie M. Fleming, Charles M. Perou, Melissa A. Troester, David McDonald, Jyla Hicks, Lynnelle Thorpe, Michael Bereman, Dereje D. Jima, Katerina D. Fagan-Solis, Katherine A. Hoadley, Denise K. Reaves
Supplementary Information including supplementary figure legends and supplementary table titles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::764e54e1792aedbfac06b8fde155eb7e
https://doi.org/10.1158/1541-7786.22511800
https://doi.org/10.1158/1541-7786.22511800
Autor:
Barbara K. Vonderhaar, Erika Ginsburg, S. Amal Hussnain, Amy F. Lin, Jodie M. Fleming, Matthew J. Meyer
Supplementary Figure 3 from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500a4b0aff40b8ff51331c1486c55295
https://doi.org/10.1158/0008-5472.22383372
https://doi.org/10.1158/0008-5472.22383372
Autor:
Barbara K. Vonderhaar, Erika Ginsburg, S. Amal Hussnain, Amy F. Lin, Jodie M. Fleming, Matthew J. Meyer
Supplementary Figure 8 from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56a400560cee747f43fd3ed824df4b0b
https://doi.org/10.1158/0008-5472.22383357.v1
https://doi.org/10.1158/0008-5472.22383357.v1